This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Duluth, Minn, March 3, 1897.
To the Editor:
—Permit me through your columns to call the attention of the regular profession throughout the United States to the fact that McKesson & Robbins of New York, hitherto considered by medical practitioners a reputable firm, have recently adopted the methods of the patent medicine vendors in putting upon the market a remedy for the cure of a certain disease and advertising the same to the general public through the secular press, as witness the following from the Literary Digest of Feb. 20, 1897.This speaks for itself, and should not be allowed to pass unnoticed by the profession at large, to which this house is looking chiefly for support.Yours truly,"Tartarlithine, the new cure for rheumatism. L. E. B., Clifton Hotel, Ottawa, Ill., writes: 'On Sunday, April 5, 1896, I was introduced to a citizen of this city who had not
Fullerton WS. Manufacturers in the Secular Press.. JAMA. 1897;XXVIII(11):518. doi:10.1001/jama.1897.02440110040016